网站大量收购闲置独家精品文档,联系QQ:2885784924

抗生素的过去、现在与将来(英文PPT)课件.ppt

抗生素的过去、现在与将来(英文PPT)课件.ppt

  1. 1、本文档共21页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
抗生素的过去、现在与将来(英文PPT)课件

Medicine. Past, Present and Future. ANTIBIOTICS Professor Anthony Coates Medical Microbiology Department of Cellular and Molecular Medicine, St George’s, University of London. Microbes kill each other with antibiotics They have developed self-defence mechanisms: 1. Non-multiplying state 2. Biofilm 3. Genetic resistance The search for antibiotics begins Bacterial genetic resistance to antibiotics begins to neutralise the beneficial effects. 1945, in an interview with The New York Times, Fleming warned that the misuse of penicillin could lead to selection of resistant forms of bacteria The solution: Make new antibiotics to replace the old ones to which resistance has emerged. Antibiotic development 1929-72 The Antibiotic Paradox, Stuart Levy, New York, Plenum Press, 1992, 4 THE PRESENT Antibiotic resistance is rising 80 70 60 50 40 30 20 10 0 1990 1995 2000 2003 Percent of Resistant Strain MRSA QRPSE MRSPN/VRE PRSPN MRSA = methicillin resistant Staphylococcus aureus VRE = vancomycin resistant enterococci MRSPN = macrolide resistant Streptococcus pneumoniae PRSPN = penicillin resistant Streptococcus pneumoniae QRPSE = quinolone resistant Pseudomonas aeruginosa The number of new antibiotics which reach the market is falling Life-or-death Crisis: The Bacteria are winning Emergence of resistance is outpacing the introduction of new antibiotics (2003 Daptomycin; 2004 none; 2005 Tygacil ) No new agents in clinical development against multi-drug resistant gram-negatives eg Pseudomonas aeruginosa, Acinetobacter spp Why has the pharmaceutical industry reduced its production of new antibiotics? Resistance emerges too quickly and reduces the effective life of an antibiotic Too little profit Big Biology has failed to produce new antibiotics Increased costs due to more regulation eg EC Litigation fears Government restrictions on use (Keep in reserve) Antibiotic

文档评论(0)

a888118a + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档